Please assess the completion status of the following clinical trial:

Trial Title: Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult males aged 18 to 50 years inclusive and body weight 65 to 100kg.~2. Subjects who are healthy as determined by pre-study medical history, physical examination, vital signs and 12 ECG.~3. Subjects whose clinical laboratory test results are normal, or where outside the reference range are judged as not clinical relevant.~Exclusion Criteria:~1. Have a history of and/or current clinically significant gastrointestinal, renal, hepatic, cardiovascular, haematological, pulmonary, neurologic, metabolic, psychiatric or allergic disease excluding mild asymptomatic seasonal allergies.~2. Subject with a psychiatric disorder or considered unsuitable for inclusion by the investigator.~3. History or current clinically significant, excluding mild asymptomatic seasonal allergies, hypersensitivity or allergic reactions including known or suspected drug hypersensitivity to any component of the study drug formulations or comparable drugs.~4. Any biological drug within 3 months or monoclonal antibodies within 9 months of study drug administration.~5. Intake of herbal remedies within 14 days prior to study drug administration.~6. History of alcohol abuse or a positive alcohol test on screening or admission to the clinical center.~7. Any persons who are:an employee of the Principal Investigator, clinical center, Clinical Research Organization (CRO) or Sponsor;a relative of an employee of the clinical center, the Investigators, CRO or the Sponsor.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- BAT1706 (Type: EXPERIMENTAL): BAT1706 injection
- EU-sourced Avastin (Type: ACTIVE_COMPARATOR): EU-sourced Avastin
- US-sourced Avastin (Type: ACTIVE_COMPARATOR): US-sourced Avastin

Based on this trial design, predict the completion outcome and termination type (if applicable).